Eligibility criteria specify which patients can enter a trial, often based on diagnoses, lab values, prior treatments or comorbidities. AI systems that simulate or optimise trials sometimes adjust these criteria; managers and policymakers must understand the term to appreciate how such changes influence recruitment feasibility, safety, generalisability of results and potential equity concerns in study populations.